Epic Sciences partners with LabCorp for circulating tumor cell technology - 0 views
-
Alex Parker on 31 Jan 14Epic Sciences has announced an agreement with Laboratory Corporation of America Holdings (LabCorp) to expedite sample processing for Epic's circulating tumor cell (CTC) technology to support European clinical trials.